Previous Article | Next Article ![]()
Journal of Bacteriology, January 2004, p. 240-243, Vol. 186, No. 1
0021-9193/04/$08.00+0 DOI: 10.1128/JB.186.1.240-243.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Consolación Pardo-Abarrio, and Ramón Díaz-Orejas*
Centro de Investigaciones Biológicas (CSIC), 28040 Madrid, Spain
Received 27 August 2003/ Accepted 30 September 2003
|
|
|---|
|
|
|---|
The first, "restrictive" approach consisted of the mutagenesis of the pAB24 plasmid, which contains the wild-type parD operon, and the consecutive screening for Kid mutants unable to corepress the parD promoter. A possible limitation of this approach was that Kid mutations that affected the interactions between Kis and Kid required for the neutralization of Kid toxicity should lead to growth inhibition and therefore could be counterselected. The second, "permissive" approach relieved this constraint: instead of pAB24, we used pB24, a mutated version of pAB24 carrying the kid85 mutation. This mutation abolishes the toxicity of the Kid protein but maintains its activity as a corepressor (13), thereby permitting the eventual isolation of kid mutations which lead to derepression by disrupting the interactions between Kis and Kid.
Thus, the pB24 or pAB24 plasmid was mutagenized in vitro with hydroxylamine as described previously (6) and this DNA was used to transform the Escherichia coli CSH16 strain (
lac supE) containing pOM34, a mini-R1 recombinant in which the lacZ gene is transcriptionally fused to the parD promoter (9). In this background, parD mutants that failed to repress in trans the parD promoter elicited ß-galactosidase synthesis and led to the formation of red transformants on MacConkey agar plates supplemented with lactose (Fig. 1A). Plasmids from red colonies were isolated and retransformed in the same strain, and those reproducing the mutant phenotype were kept for further analysis. The sequences of the complete parD operon in each of the mutant plasmids were determined and led to the identification of 11 different mutations in the kid gene (Fig. 1B). As expected from the mutagenic action of hydroxylamine, the changes isolated were C-G/A-T transitions and introduced missense or nonsense mutations. The latter led to truncated proteins that were not toxic (data not shown), in agreement with previous data that showed the relevance of the carboxyl end of the protein in toxicity (4, 12).
![]() View larger version (35K): [in a new window] |
FIG. 1. Kid mutations that affect the autoregulation of the parD system. (A) CSH16 cells carrying the reporter of parD expression plasmid pOM34 and the mutated derivatives of plasmid pB24 (Tetr kis74 kid85) or pAB24 (Tetr kis+ kid+) were streaked on MacConkey agar plates supplemented with lactose, tetracycline (10 µg per ml), and ampicillin (50 µg per ml). The plates were photographed after a 12-h incubation at 30°C. (B) Localization of the mutations. Mutations that were isolated by both approaches, i.e., that were found in pAB24 and also in pB24, are included in a grey box. For clarity, their localization is indicated only on the pAB24 sketch. Mutations that were isolated only in pAB24 or pB24 are indicated above and below the corresponding plasmid representation, respectively. Asterisks denote mutations that were described in a previous work as mutations that affect both the toxicity and autoregulatory activities of Kid (13).
|
To test these hypotheses, each of the kid74, kid79, and kid87 mutations was introduced separately in pAB24 by using a site-directed mutagenesis kit (Promega). The resultant plasmids were used to transform the MLM373 strain [
(lac, pro) supE thi)] (13), which also contained the pMLM132 plasmid, a mini-F derivative that bears the lacZ gene under the control of the parD promoter (13). parD expression levels were monitored in ß-galactosidase assays that were carried out as described previously (8). The Kid changes T79A and G87R did not significantly affect the autoregulatory activity of the protein (Fig. 2A), confirming that the deregulation phenotypes associated with the kid79 and kid87 mutations were due to interactions with the kid85 or kis74 mutation present in pB24. In contrast, the Kid C74Y change provoked a fivefold increase in parD promoter activity (Fig. 2A), confirming that the single C74Y change was sufficient to lead to deregulation. Furthermore, growth was severely inhibited in cells that contained the pAB24 plasmid bearing the kid74 mutation but not in those that contained the other mutant or wild-type pAB24 plasmid (Fig. 2B). Growth inhibition was not observed when the kid74 mutation was present in pB24 (data not shown; see also Fig. 1A). Therefore, this indicates that the C74Y change has been counterselected by the pAB24 restrictive approach and that the negative effect of a Kid C74Y change is suppressed by the mutations present in pB24. In addition, these experiments confirmed that the kid4(G4E) and kid91(E91K) mutations lead to deregulation of parD expression, as revealed by the respective six- and threefold increases in ß-galactosidase activity (Fig. 2A).
![]() View larger version (12K): [in a new window] |
FIG. 2. Effect of mutations on parD autoregulation and cell growth. (A) Autoregulation. MLM373 cells containing the parDp-lacZ fusion carrier plasmid pMLM132 and the derivatives of the pAB24 plasmid carrying the different mutations were grown to mid-exponential phase in Luria broth (LB) containing tetracycline (10 µg per ml) and chloramphenicol (20 µg per ml) at 37°C. ß-Galactosidase activity was measured from aliquots of the cultures as described previously (8). Error bars represent the standard deviations calculated from three independent experiments. For the negative control (rightmost lane), pBR322 was used instead of pAB24. (B) Growth of MLM373 cells containing the different pAB24 mutant plasmids. Overnight cultures at 37°C in LB broth containing tetracycline were diluted in the same medium to an A600 of 0.02 to 0.04 and were grown at 37°C with aeration. Samples were removed at the times indicated to measure optical density at a wavelength of 600 nm. The graphic shows a typical pattern that was reproduced in three independent experiments.
|
![]() View larger version (33K): [in a new window] |
FIG. 3. Analysis of toxicity of the Kid mutants and neutralization by the Kis antitoxin. BL21(DE3) cells carrying the kis overproducer plasmid pMLM126 and the different pET3d-hiskid wild-type or mutant plasmids were grown exponentially to an A600 of 0.4 in Luria broth (LB) medium containing ampicillin (50 µg per ml), chloramphenicol (20 µg per ml), and arabinose (0.2%). The cultures were washed twice in LB medium, and serial dilutions (10-1 steps from left to right) of the different cultures were spotted on plates containing LB medium solidified with agar and supplemented with the same antibiotics. In addition, arabinose (0.2%) was present in the plates shown in the panels A and D, and IPTG (0.1 mM) was included in the plates shown in panels C and D. The plates were placed at 30°C, and the photographs were taken after 24 h of incubation.
|
This hypothesis is supported by the recent structural data on the closely related MazE-MazF TA complex, which argues in favor of a rearrangement of the complex upon DNA binding (7). Strikingly, the C74 residue is bordered by two residues, R73 and D75, that are essential for the toxic activity of Kid (13). Moreover, the region of the homologous MazF toxin that corresponds to the R73-D75 region of Kid is involved in contacts with the carboxy-terminal region of the MazE antitoxin, suggesting that the C74 residue might be crucial for Kis-Kid interactions required for neutralization as well as for autoregulation. Finally, the E91K mutant protein is neutralized by the Kis antitoxin, provided that the latter is present in excess. Perhaps the most striking feature of this mutant is that, compared with the wild-type toxin, its dramatic cytotoxic effect requires very low levels of expression. It might be that the E91K change favors a more efficient interaction of the Kid toxin with its target, in a manner that is less efficiently competed by the Kis antitoxin. Support for this hypothesis has been provided by the structural analyses of the Kid toxin and of the MazE-MazF complexes, which suggest that the target may compete with the C-terminal region of the antitoxin to bind to the toxin (7, 4). Addressing this issue awaits further structural and functional information on toxin-target complexes, as well as on autoregulation complexes bound to DNA.
Present address: Institut für Biochemische Pharmakologie, Universität Innsbruck, A-6020 Innsbruck, Austria. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»